Swan RL[au] - Search Results

Year	Number of Results
1895	1
2001	1
2013	1
2018	2
2019	2
2020	1
2021	1

1

TOP2B: The First Thirty Years.

Austin CA, Lee KC, Swan RL, Khazeem MM, Manville CM, Cridland P, Treumann A, Porter A, Morris NJ, Cowell IG. Austin CA, et al. Among authors: swan rl. Int J Mol Sci. 2018 Sep 14;19(9):2765. doi: 10.3390/ijms19092765. Int J Mol Sci. 2018. PMID: 30223465 Free PMC article. Review.

2

Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.

Atwal M, Swan RL, Rowe C, Lee KC, Lee DC, Armstrong L, Cowell IG, Austin CA. Atwal M, et al. Among authors: swan rl. Mol Pharmacol. 2019 Oct;96(4):475-484. doi: 10.1124/mol.119.117259. Epub 2019 Aug 9. Mol Pharmacol. 2019. PMID: 31399497 Free PMC article.

3

Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes.

Swan RL, Poh LLK, Cowell IG, Austin CA. Swan RL, et al. Mol Pharmacol. 2020 Sep;98(3):222-233. doi: 10.1124/mol.119.118893. Epub 2020 Jun 25. Mol Pharmacol. 2020. PMID: 32587095 Free PMC article.

4

The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison.

Cowell IG, Ling EM, Swan RL, Brooks MLW, Austin CA. Cowell IG, et al. Among authors: swan rl. Mol Pharmacol. 2019 Nov;96(5):562-572. doi: 10.1124/mol.119.117390. Epub 2019 Sep 12. Mol Pharmacol. 2019. PMID: 31515282 Free PMC article.

5

Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA Complexes.

Lee KC, Swan RL, Sondka Z, Padget K, Cowell IG, Austin CA. Lee KC, et al. Among authors: swan rl. Int J Mol Sci. 2018 Jul 14;19(7):2056. doi: 10.3390/ijms19072056. Int J Mol Sci. 2018. PMID: 30011940 Free PMC article.

6

A rare case of empyema. Answer: Transformation of CLL into diffuse large B-cell lymphoma, also known as Richter syndrome.

Yager NM, Ghate K, Swan RL, Farrokh A, Barba K, Beegle SH. Yager NM, et al. Among authors: swan rl. Chest. 2013 Jul;144(1):350-353. doi: 10.1378/chest.12-2732. Chest. 2013. PMID: 23880686 No abstract available.

7

A role for VCP/p97 in the processing of drug-stabilised TOP2-DNA covalent complexes.

Swan RL, Cowell IG, Austin CA. Swan RL, et al. Mol Pharmacol. 2021 May 3:MOLPHARM-AR-2021-000262. doi: 10.1124/molpharm.121.000262. Online ahead of print. Mol Pharmacol. 2021. PMID: 33941661 Free article.

8

Seasonal variation in glucocorticoid receptor binding characteristics in human mononuclear leucocytes.

Blackhurst G, McElroy PK, Fraser R, Swan RL, Connell JM. Blackhurst G, et al. Among authors: swan rl. Clin Endocrinol (Oxf). 2001 Nov;55(5):683-8. doi: 10.1046/j.1365-2265.2001.01383.x. Clin Endocrinol (Oxf). 2001. PMID: 11894981

9

A Method of Treating Inversion of the Limb Subsequent to the Cure of Equino-Varus.

Swan RL. Swan RL. Br Med J. 1895 Jun 15;1(1798):1317-8. doi: 10.1136/bmj.1.1798.1317. Br Med J. 1895. PMID: 20755591 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results